Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06270511 · ClinicalTrials.gov registry record · Phase 1

A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants

A Phase 1 study of Healthy Volunteers, sponsored by Shionogi.

Completed
Registry status
Phase 1
Development phase
50
Enrollment target
1
Study location

NCT06270511 is a Phase 1 study of Healthy Volunteers that has completed, run by Shionogi. The registered enrollment target is 50 participants, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06270511, a Phase 1 study of Healthy Volunteers, has completed, sponsored by Shionogi.

COMPLETED
Registry status
Phase 1
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to investigate different formulations of S-337395.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG S-337395

Study Locations (1)

Kansas

  • ICON Lenexa - Lenexa

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-03-13
Est. Completion 2024-06-19
Phase Phase 1

Sponsor

Shionogi

54 total trials

What the Registry Record Tells You About NCT06270511

The ClinicalTrials.gov registry entry for NCT06270511 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (90% lower). The listed sponsor is Shionogi, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06270511 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT06270511 about?

NCT06270511 is a clinical study titled "A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants". The aim of this study is to investigate different formulations of S-337395.

What is the current status of trial NCT06270511?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2024-03-13. Estimated completion is 2024-06-19.

What conditions does trial NCT06270511 study?

This clinical trial studies the following conditions: Healthy Volunteers.

What interventions are being tested in trial NCT06270511?

The interventions under investigation include: Placebo (DRUG), S-337395 (DRUG).

Who is sponsoring clinical trial NCT06270511?

This trial is sponsored by Shionogi, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06270511 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.